Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Apollo Endosurgery, Inc. (APEN)

5.74   -0.26 (-4.33%) 11-28 09:58
Open: 5.91 Pre. Close: 6
High: 6 Low: 5.74
Volume: 4,669 Market Cap: 239(M)

Technical analysis

as of: 2022-11-28 9:46:22 AM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 7.69     One year: 8.49
Support: Support1: 5.48    Support2: 4.55
Resistance: Resistance1: 6.58    Resistance2: 7.26
Pivot: 6.25
Moving Average: MA(5): 5.95     MA(20): 6.33
MA(100): 5.79     MA(250): 5.72
MACD: MACD(12,26): -0.1     Signal(9): 0
Stochastic oscillator: %K(14,3): 30.9     %D(3): 29.5
RSI: RSI(14): 42.7
52-week: High: 9.1  Low: 3.49
Average Vol(K): 3-Month: 99 (K)  10-Days: 70 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ APEN ] has closed above bottom band by 19.4%. Bollinger Bands are 11.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.06 - 6.08 6.08 - 6.11
Low: 5.85 - 5.88 5.88 - 5.9
Close: 5.96 - 6 6 - 6.04

Company Description

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

Headline News

Sun, 27 Nov 2022
5-year-old girl is missing after mother was found dead in South Carolina - Yahoo News

Sat, 26 Nov 2022
NDTV investors tender shares for nearly a Quarter of apen offer by adani - STL.News

Mon, 07 Nov 2022
2022-11-07 | NDAQ:APEN | Press Release | Apollo Endosurgery Inc. - Stockhouse

Sat, 05 Nov 2022
NDB introduces “Sallli Ratin – Thagi Apen 2” for Remittances for the second time - The

Thu, 03 Nov 2022
Apollo Endosurgery Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Tue, 01 Nov 2022
Apollo Endosurgery, Inc. 2022 Q3 - Results - Earnings Call Presentation (NASDAQ:APEN) - Seeking Alpha

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 42 (M)
Shares Float 32 (M)
% Held by Insiders 7.8 (%)
% Held by Institutions 74.3 (%)
Shares Short 1,110 (K)
Shares Short P.Month 1,370 (K)

Stock Financials

EPS -0.86
EPS Est Next Qtl -0.38
EPS Est This Year -2.07
EPS Est Next Year -1.3
Book Value (p.s.) 1.01
Profit Margin (%) -56.8
Operating Margin (%) -36
Return on Assets (ttm) -17.3
Return on Equity (ttm) -192.8
Qtrly Rev. Growth 19.7
Gross Profit (p.s.) 0.83
Sales Per Share 1.72
EBITDA (p.s.) -0.55
Qtrly Earnings Growth 0
Operating Cash Flow -25 (M)
Levered Free Cash Flow -16 (M)

Stock Valuations

PE Ratio -6.96
PEG Ratio 0
Price to Book value 5.79
Price to Sales 3.43
Price to Cash Flow -9.73

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2016-12-29
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.